You have 9 free searches left this month | for more free features.

Beijing (1)

Tianjin (1)

AML (1)

Advanced Solid Tumor (1)

MDS (1)

Active, not recruiting (1)

Unknown status (1)

phase 1 (2)

Jiangsu HengRui Medicine Co., Ltd. (2)

shr-1702 (2)

camrelizumab (1)

drug (2)

Industry (2)

Interventional (2)

shr-1702

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Tianjin, Tianjin, China

Blood disease hospital of Chinese Academy of Medical Sciences

Mar 7, 2022

Unknown status

Mar 10, 2019